You should focus on key developments such as 3D Assays and Automation, Software, Primary cells, Signaling and Reporter genes
DUBLIN, Jan. 18, 2023 /PRNewswire/ “Cell Based Assay & High Content Screening Markets. Forecasts by User and Product. With Executive and Consultant Guides. including Customized Forecasting and Analysis. 2022 to 2026” A report has been added ResearchAndMarkets.com’s offering.
Cell Based Assays have been a keystay in drug development and scientific research. Now, after the pandemic, there is more activity. Cell Based Assays can now be used for any aspect of cell function.
The market is growing at an unstoppable pace. Biotechnology is becoming the central focus of the industry that has been the workhorse for the pharmaceutical industry.
This is a complex area. However, this report will provide a clear overview to the entire management team on the technology and the potential. The market is not keeping up with technology.
Genomics, Immunology and other areas play an important role. Learn the risks and opportunities. Know your market potential and growth expectations.
We cover the following key topics:
1. Market Guides
1.1 Analysis of the Situation
1.2 Guide for Marketing Executives and Staff
1.3 Guide for Management Consultants and Investment Analysts
2. Introduction and Market Definition
2.1 What is Cell Based Assays?
2.2 Clinical Trial Rejects
2.2.1 The Role of Immuno-oncology in Cell Based Assays
2.3 Infectious Diseases Will Play a Greater Role
2.4 Market Definition
2.4.1 Market Size
2.4.2 Currency
2.4.3 Years
2.5 Methodology
2.5.1 Authors
2.5.2 Sources
2.6 U.S. Medical Market, Pharmaceutical Research Spending –Perspective
1.5.1 U.S. 1.5.1 US
3. Cell Based Assays: A Guide to Technology
3.1 Cell Cultures
3.1.1 Cell Phone Lines
3.1.2 Primary cells
3.1.3 Stem Cells
3.1.4 iPSC – The Special Case
3.2 Cell Assays
3.3 Cell viability assays
3.4 Cell Proliferation Assays
3.5 Cytotoxicity Tests
3.6 Cell Senescence Assays
3.7 Apoptosis
3.8 Autophagy
3.9 Necrosis
3.10 Oxidative Stress
3.11 2D vs. 3D
3.12 Signalling Pathways GPCR
3.13 Immune Regulation & Inhibition
3.14 Reporter Gene Technology
3.15 CBA Design & Development
3.16 Cell Based Assays: The Takeaway
4. Industries Overview
4.1 Market Players
4.1.1 Academic Research Lab
4.1.2 Contract Research Organization
4.1.3 Supplier of Genomic Instrumentation
4.1.4 Cell Separation & Viewing Supplier
4.1.5 Cell line and Reagent Supplier
4.1.6 Pharmaceutical Company
4.1.7 Audit Body
4.1.8 Certification Body
5. Market Trends
5.1 Factors that Drive Growth
5.1.1 Candidate growth
5.1.2 Immuno-oncology
5.1.3 Genomic Blizzard
5.1.4 Technology Convergence
5.1.5 The insurance effect
5.2 Factors Limiting Growth
5.2.1 CBA Development Challenges
5.2.2 Integration of Instruments
5.2.3 Protocols
5.3 Technology Development
5.3.1 Assays in 3D
5.3.2 Automation
Software 5.3.3
5.3.4 Primary Cells
5.3.5 Signaling and reporter genes
5.3.6 The Next Five Years
6. Recent Cell Based Assays
6.1 Recent Developments: Importance and Use of This Section
6.1.1 The Importance These Developments
6.1.2 How to Use the Section
Nanolive closes at 6.2 USD 20,000,000 Round of Funding
6.3 Depixus aims to commercialize the ‘Magnetic Tweezers,’ for drug discovery
BioAuxilium Research Expands Its Cell Signaling Assay Portfolio
6.5 Droplet Genomics Launches New Microfluidic Screening Platform
6.6 DLP + Single-Cell Sequencing Method Spreads Worldwide from Canada to Cancer Labs Worldwide
6.7 Secondcell Bio makes it easy to create cell lines
6.8 Nanolitre-scale Cell Assays Developed with Droplet Microarray Mass Spec
6.9 Thermo- Fisher Scientific Acquires Cell Sorting Technology
6.10 Cellink to Distribute Phasefocus-High-Content Cell Imaging Platform
6.11 Axxam & FUJIFILM Cellular Dynamics Announce Strategic Alliance
6.12 Cancer Genetics to Acquire Organoid Startup Stemonix
6.13 Curi Bio Purchases Artificial Intelligence Firm Dana Solutions
6.14 CRISPR Screens Reveal Novel Cancer Therapy Targets
6.15 ERS Genomics Licences CRISPR–Cas9 Patents to Axxam
6.16 A New Transcriptomics Assay Facilitates Complex Screens
6.17 Carta Biosciences betting on gene interaction mapping
6.18 High-throughput identification of cancer drug candidates
6.19 Velabs Therapeutics and Alytas Therapeutics team up to create a new immune-based treatment for obesity
6.20 InSphero platform chosen to test Cyclerion’s sGC stimulator tech
6.21 OcellO to offer in vitro research services for Merus
6.22 Charles River Laboratories will acquire Citoxlab
6.23 Reaction Biology Corporation purchases ProQinase GmbH
7. Profiles of Key Cell Based Assay Companies
7.1 Abcam
7.2 Agilent
7.3 Aurora Instruments Ltd.
7.4 Axxam
7.5 Beckman Coulter Diagnostics
7.6 Becton, Dickinson and Company
7.7 BioIVT
7.8 Bio-Rad Laboratories, Inc.
7.9 BioTek instruments
7.10 BioVision, Inc.
7.11 BMG Labtech
7.12 Cell Biolabs, Inc.
7.13 Cell Signaling Technology, Inc.
7.14 Charles River Laboratories
7.15 Cisbio Bioassays
7.16 Corning, Inc.
7.17 Cytovale
7.18 Enzo Life Sciences, Inc.
7.19 Eurofins DiscoverX Corporation
7.20 Evotec AG
7.21 Excellerate Life Science
7.22 Fujifilm Cellular Dynamics International
7.23 Genedata
7.24 Hemogenix
7.25 Horizon Discovery
7.26 Invivogen
7.27 Leica Biosystems
7.28 Lonza Group Ltd.
7.29 Luminex Corp
7.30 Merck & Co., Inc
7.31 Miltenyi Biotec
7.32 Molecular Devices
7.33 Nanion
7.34 Ncardia
7.35 New England Biolabs, Inc.
7.36 Olympus
7.37 Origene Technologies
7.38 Perkin Elmer
7.39 Promega
7.40 Qiagen Gmbh
7.41 Reaction Biology
7.42 Recursion Pharma
7.43 Roche Diagnostics
7.44 Sartorius
7.45 Sartorius-ForteBio
7.46 Sartorius-IntelliCyt
7.47 Sony Biotechnology
7.48 SPT Labtech
7.49 Stemcells Technologies Canada Inc.
7.50 Tecan
7.51 Thermo Fisher Scientific Inc.
7.52 Vitro Biopharma
8. Global Market Size
8.1 Global Market Overview, Country
8.2 Global Market by User Overview
8.3 Global Market by Product Category – Overview
9. Global Market by User Type
9.1 Pharma
9.2 Research
9.3 Industry/Cosmetic
10. Cell Based Assay for Product Class
10.
10.2 Reagent
10.3 Services
10.4 Software
11. Appendices
11.1 FDA Cancer Drug Aprovals by Year
11.2 Clinical trials started 2010-2016
11.3 Share of Pharma R&D by Country
Visit this site for more information. https://www.researchandmarkets.com/r/nrlsez
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world’s leading source for international market research reports and market data. We offer the most current data on the global and regional markets, top companies, and new products.
Media Contact
Research and Markets
Laura WoodSenior Manager
[email protected]
For E.S.T Hours, Call +1-917-300-0470
Toll-free call +1 800 526-8630 for U.S./CAN
For GMT Office Hours: Call +353-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Logo: https://mma.prnewswire.com/media/539438/Research_and_Markets_Logo.jpg
SOURCE Research and Markets